We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$43.8B
AUM Growth
+$2.95B
(+7.2%)
Cap. Flow
+$2.92B
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
29.71%
Holding
2,321
New
255
Increased
1,689
Reduced
325
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$408M |
| 2 |
NVIDIA
NVDA
|
+$395M |
| 3 |
Microsoft
MSFT
|
+$382M |
| 4 |
Amazon
AMZN
|
+$253M |
| 5 |
Palantir
PLTR
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$285M |
| 2 |
NextEra Energy
NEE
|
+$207M |
| 3 |
West Pharmaceutical
WST
|
+$168M |
| 4 |
Broadcom
AVGO
|
+$133M |
| 5 |
Meta Platforms (Facebook)
META
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.42% |
| 2 | Consumer Discretionary | 10.78% |
| 3 | Consumer Staples | 10.15% |
| 4 | Industrials | 10.05% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OSG
1926
Octave Specialty Group
OSG
$252M
| $174K | ﹤0.01% |
+13,756
| New | +$166K |
|
1927
Relay Therapeutics
RLAY
$4.02B
| $174K | ﹤0.01% |
42,200
+15,492
| +58% | +$84.3K |
|
|
SNCY
1928
DELISTED
Sun Country Airlines
SNCY
| $173K | ﹤0.01% |
+11,896
| New | +$161K |
|
1929
PubMatic
PUBM
$581M
| $173K | ﹤0.01% |
+11,775
| New | +$182K |
|
|
ORC
1930
Orchid Island Capital
ORC
$1.31B
| $172K | ﹤0.01% |
22,162
+8,633
| +64% | +$67.9K |
|
1931
Green Dot
GDOT
$753M
| $172K | ﹤0.01% |
16,192
+5,089
| +46% | +$56.1K |
|
|
LPRO
1932
Open Lending Corp
LPRO
$373M
| $172K | ﹤0.01% |
28,777
+9,468
| +49% | +$56.7K |
|
|
CRGX
1933
DELISTED
CARGO Therapeutics
CRGX
| $171K | ﹤0.01% |
+11,849
| New | +$215K |
|
1934
Barings BDC
BBDC
$862M
| $170K | ﹤0.01% |
17,809
+2,333
| +15% | +$22.8K |
|
1935
Altimmune
ALT
$539M
| $169K | ﹤0.01% |
23,371
+9,950
| +74% | +$76K |
|
1936
Thryv Holdings
THRY
$169M
| $167K | ﹤0.01% |
+11,312
| New | +$178K |
|
1937
Alvotech
ALVO
$1.03B
| $167K | ﹤0.01% |
+12,639
| New | +$156K |
|
1938
Keros Therapeutics
KROS
$199M
| $167K | ﹤0.01% |
10,549
+2,764
| +36% | +$144K |
|
1939
Annexon
ANNX
$855M
| $167K | ﹤0.01% |
32,548
+14,475
| +80% | +$89.1K |
|
1940
Oric Pharmaceuticals
ORIC
$1.25B
| $167K | ﹤0.01% |
20,683
+4,881
| +31% | +$44.8K |
|
1941
Hain Celestial
HAIN
$47.8M
| $166K | ﹤0.01% |
27,039
+8,322
| +44% | +$66.6K |
|
|
ADAM
1942
Adamas Trust
ADAM
$777M
| $166K | ﹤0.01% |
27,346
-10,510
| -28% | -$61.8K |
|
1943
Genco Shipping & Trading
GNK
$1.17B
| $166K | ﹤0.01% |
+11,879
| New | +$193K |
|
1944
Agilon Health
AGL
$1.64B
| $165K | ﹤0.01% |
3,475
+1,143
| +49% | +$69.1K |
|
1945
Pacific Biosciences
PACB
$422M
| $165K | ﹤0.01% |
90,008
+22,215
| +33% | +$43.4K |
|
1946
Arbutus Biopharma
ABUS
$865M
| $164K | ﹤0.01% |
50,121
+11,359
| +29% | +$41.8K |
|
1947
Erasca
ERAS
$6.63B
| $164K | ﹤0.01% |
65,155
+14,921
| +30% | +$40.9K |
|
1948
SI-BONE Inc
SIBN
$737M
| $163K | ﹤0.01% |
+11,599
| New | +$156K |
|
1949
B&G Foods
BGS
$285M
| $162K | ﹤0.01% |
23,456
+7,211
| +44% | +$54.3K |
|
1950
CorMedix
CRMD
$617M
| $162K | ﹤0.01% |
19,947
+9,568
| +92% | +$95.6K |
|
Similar funds
ProShare Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, ProShare Advisors held 2,321 positions worth $43.8B, up 7.2% from $40.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
ProShare Advisors deployed $2.92B of net new capital in Q4 2024, opening 255 new positions and adding to 1,689 existing holdings. Its largest new stake was Applovin: 338,942 shares worth $110M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Walmart Inc, an estimated $285M trimmed.
- ProShare Advisors's largest Q4 2024 buy was Applovin: 338,942 shares worth $110M.
- ProShare Advisors added most to Apple in Q4 2024, an estimated $408M increase.
- ProShare Advisors's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $285M.
- ProShare Advisors fully exited PetIQ, Inc. Class A Common Stock in Q4 2024, selling an estimated $3.25M.
- ProShare Advisors's ten largest holdings make up 30% of its $43.8B portfolio in Q4 2024.
- ProShare Advisors opened 255 new positions and closed 50 in Q4 2024.
- ProShare Advisors's portfolio value rose 7.2% quarter-over-quarter to $43.8B.
Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.